Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
 
Home
 
Registration
Keynote Speakers (TBA)
Industry Panel Discussion (TBA)


The Largest East Coast Strategic Partnership and Investment Meeting for Medical Technology Executives

In3 East is simply where you will meet the most important people in medical technology partnering.
As the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives, hundreds of venture capital companies and medical technology companies gather each year to hear about the latest innovations and investment opportunities, especially in the following areas:

  • Cardiovascular/Interventional Cardiology
  • Diagnostics
  • Drug Delivery
  • Imaging
  • Minimally Invasive Surgery
  • Nanotechnology
  • Neurostimulation
  • Orthopedics/Spine
  • Peripheral Vascular
  • Stem Cells
  • Stroke Management
  • Wound Management

... among many other high-growth areas

And when you’re not networking, you’ll benefit from any of the following discussed at the meeting:

  • Keynote presentations, on-stage interviews, investment and financing panel discussions by prominent device industry executives
  • Venture capital dealmaking presentations
  • Buy side panels
  • Educational workshops for start-up companies
  • Company presentations from more than 50 emerging medical technology companies seeking funding and/or strategic partnership
Advisory Board

Jeffrey Barnes
General Partner
Oxford Bioscience Partners

Annette Campbell-White
Senior Managing Member MedVenture Associates

Michael Carusi
General Partner
Advanced Technology Ventures

Luke Evnin
General Partner
MPM Capital

Richard M. Ferrari
Managing Director
DeNovo Ventures

William T. Harrington
Partner
Three Arch Partners

Ross A. Jaffe
Managing Director
Versant Ventures

Ellen Koskinas
Partner
InterWest Partners

Josh Makower
Venture Partner
NEA

John Maroney
General Partner
Delphi Ventures

David Milne
Managing Partner
SV Life Science Advisers

Trevor J. Moody
Partner
Frazier Healthcare Ventures

Jesse I Treu
Partner
Domain Associates
For more information, please contact Kristy Grimes at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com
back to top

Presenting Companies

S

Presenting Companies/
Locations

Technologies
ACell, Inc. (First-Time Presenter)
Columbia, MD

 ACell, Inc. offers next generation extracellular matrix (“ECM”) devices that repair and remodel damaged tissues.

Advanced BioSensors, Inc.
Mentor, OH
 Continuous glucose bio-sensor platform, wireless, ambulatory, MEMS fabricated, nano processed, percutaneous, dermal, painless and accurate.

AugmentRx Medical, Inc. (First-Time Presenter)
Shelburne, VT 		Injectable porous scaffolds, spheres and composites with fully interconnected pores. Nonmigratory, nonantigenic providing sustainable tissue volume and stability for multiple applications.
AxoGen, Inc. (First-Time Presenter)
Gainesville, FL		 We return quality of life to patients by creating and delivering superior peripheral nerve solutions.
Cardiola, Ltd.
Winterthur, Switzerland		 Non-invasive Chronic Heart Failure treatment device with CE certification using patented Muscular Counter Pulsation (MCP) technology.
CardioMag Imaging, Inc. (First-Time Presenter)
Schenectady, NY		 Non-invasive devices to identify patients with coronary artery disease and other life threatening cardiovascular conditions.
Ceragenix Pharmaceuticals
Denver, CO		 Ceragenix Pharmaceuticals is developing its "Cerashield" line of antimicrobial coatings to prevent microbial colonization and biofilm formation of endotracheal tubes and other indwelling medical devices.
Cerapedics, Inc.
Westminster, CO
Cerapedics, Inc. is developing and commercializing innovative osteobiologic products based on its proprietary small peptide technology for spine, trauma and orthopaedic applications.

Core Essence Orthopaedics Inc. (First-Time Presenter)
Yardley, PA
 Core Essence Orthopaedics, Inc. is a privately held orthopaedic device company focused on intuitive, enabling solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair.

CoreSpine Technologies
Minneapolis, MN		 CoreSpine will prepare the spinal disc for a nucleus replacement or minimally invasive fusion device.
Curative Biosciences, Inc. (First-Time Presenter)
Waltham, MA
 Leader in the development of novel, proprietary biomaterial and biologic combination products for the repair and regeneration of orthopaedic injury.
CVAC Systems, Inc.
Temecula, CA
 A new, noninvasive modality to treat diabetic neuropathy—a potential $12 billion annual U.S. market.
Delcath Systems, Inc. (First-Time Presenter)
New York, NY
 Delcath is a developmental stage medical device company testing a high-dose drug delivery system for the treatment of liver cancers.
DermTech International
LaJolla, CA
 DermTech is developing non-invasive molecular diagnostics for the early detection of melanoma and other diseases, theranostics and drug development.
Diopsys (First-Time Presenter)
Pine Brook, NJ		 Provider of non-invasive medical devices that test for neuro-visual disorders.
Discovery Technology International, LLP (First-Time Presenter)
Sarasota, FL

Discovery Technology International, LLP ("DTI") has developed a unique, proprietary piezoelectric technology utilized in finished products designed for micro surgical, robotics, microscopy, and bio sensors with applications in gene expression, neuro, and nanotechnology.

eCardio Diagnostics
The Woodlands, TX

eCardio Diagnostics, www.eCardio.com, is the leading North American provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring, and subsequent clinical management of cardiac arrhythmias.
Endosense SA
Geneva, Switzerland		 Company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias.
EndoSphere Inc. (First-Time Presenter)
Redwood City, CA		 EndoSphere is in human trials with an endoscopically implantable device that assists patients in losing weight and controlling Type 2 diabetes.

Envisionier Medical Technologies
Rockville, MD		 Envisionier Medical Technologies, Inc. is the leader in development of portable endoscopic imaging technology with the endogo® visualization system and related products.
EyeMarker Systems, Inc. (First-Time Presenter)
Morgantown, WV		 Automated handheld RTD1000 (3lbs) provides rapid (3 minutes), non-invasive triage and detection of pre-symptomatic exposure to systemic diseases, toxins, and internal injury via the eye.

FAST Diagnostics (First-Time Presenter)
Indianapolis, IN
 FAST Diagnostics is using fluorescent markers and optical sensors to develop a measurement of kidney function.
Genesis Medical Interventional, Inc.
Redwood City, CA
 Instant On/Instant Off Proximal Occlusion Funnel Catheter™ for Embolectomy and Thrombectomy during Percutaneous Vascular Procedures.
Healionics Corporation
Redmond, WA

3D tissue scaffold materials and structures providing enhanced biocompatibility and bio-integration of medical devices.

HemoSonics (First-Time Presenter)
Charlottesville, VA

 HemoSonics is developing a point-of-care analyzer to quantify hemostasis in whole blood.

HydroCision, Inc.
Billerica, MA
 Fluidjet devices for open/MIS spine procedures including fusion, discectomy, artificial nucleus, and disc procedures.
Infoscitex Corporation (First-Time Presenter)
Waltham, MA		 Consistent with the desire to improve care for trauma victims, Infoscitex (IST) in collaboration with Children’s Hospital Boston has initiated development of a computer-assisted, steerable, handheld, laparoscopic tool (CASHLT). The CASHLT would enable hybrid surgical procedures, drawing on the best in technique and technology from laparoscopy, hand-assisted surgery, traditional open surgery, and robotic surgery.
Inovio Biomedical Corporation (First-Time Presenter)
San Diego, CA		 Inovio Biomedical (AMEX: INO) is focused on developing electroporation-delivered DNA-based vaccines against cancers and infectious diseases.
Inset Inc. (First-Time Presenter)
Mt. Olive, NJ		 Targeted intraspinal drug delivery with implantable programmable pump. IDE clinicals completed and under PMA review.
InspireMD (First-Time Presenter)
Tel Aviv, Israel		 InspireMd develops a new generation of stents. MGuard is CE marked and distributed in Europe & S. America. Clinical results position us as a leader in safety and efficacy.

Intellwave, LLC
Edison, NJ

 World wide leader in Heart Rate Variability (HRV) analysis for quantitative assessment of the Autonomic Nervous System (ANS) - 510k clearance - Columbia Univerisity validated.

Lerner Medical Devices (First-Time Presenter)
Los Angeles, CA		 Lerner Medical Devices, Inc., using its unique and proprietary UV phototherapy technology, is developing for launch in 2009, home-use medical devices for the treatment of psoriasis and other photoresponsive skin diseases.
LifeBond Ltd. (First-Time Presenter)
Caesarea, Israel		 LifeBond is developing strongly adhesive sealants and hemostats for surgical use. The natural polymer technology mimics the physiological clotting cascade without reliance on blood-derived proteins and can be used to staunch severe bleeding, reinforce staple and suture lines, and repair tissues.
LineaGen, Inc. (First-Time Presenter)
Salt Lake City, UT
Content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests.
LRS Ortho (First-Time Presenter)
Nazareth, Israel
 Smart accurate guiding device based on image technology for orthopedic trauma procedures such Intramedullary nails, Osteotomy and others.

MicroTransponder Inc. (First-Time Presenter)
Dallas, TX 		MicroTransponder has developed a wireless neurostimulation device to treat refractory chronic pain. Our device is 100 times smaller than current technology and injectable via a minimally invasive hypodermic needle.

Minnow Medical
San Diego, CA		 New catheter treatment to restore blood flow to arteries by reducing plaque volume and increasing the artery diameter.
mNemoscience GmbH
Aachen, Germany
 mNemoscience is pioneering the design and manufacture of innovative biocompatible shape memory polymers (BIO-SMP) which can be programmed to change shapes and rigidity when an initiating stimulus, such as e.g. change in temperature, is applied.
MTM Laboratories (First-Time Presenter)
Westborough, MA 		Biomarkers for the screening and diagnosis of cancers; initial focus is on Cervical Cancer.
nContact Surgical, Inc. (First-Time Presenter)
Morrisville, NC

nContact Surgical is focused on commercializing novel cardiac coagulation systems that enable endoscopic, “port access” minimally invasive for the treatment of atrial fibrillation.
NeoMend, Inc.
Irvine, CA
 NeoMend is a biomaterials company commercializing advanced wound management products based upon its proprietary polymer hydrogel technology.
Nerites Corporation
Madison, WI		 Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices.

Osprey Medical (First-Time Presenter)
St. Paul, MN		 Osprey Medical’s CINCOR™ system is designed to prevent contrast media, used in coronary procedures, from causing kidney damage.
PEAK Surgical, Inc. (First-Time Presenter)
Palo Alto, CA		 PEAK Surgical’s technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral tissue damage.
Polymedix, Inc.
Radnor, PA 		Novel anti-microbial polymeric coatings for devices and implants.
Respirion, Inc. (First-Time Presenter)
Trabuco Canyon, CA		 Stent technology to treat obstructive sleep apnea.
Rosetta Genomics (First-Time Presenter)
Jersey City, NJ
 First biotech company to focus on commercially developing molecular diagnostics and therapeutics using microRNA-based technology.
Science Applications International Corporation (First-Time Presenter)
Newport, RI
 Developed and integrated all the key elements of a real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited FAST examination.
Scil Technology GmbH
Martinsried, Germany
 Innovative product for tissue regeneration through bridging of growth factors and biomaterials.
Sensimed AG (First-Time Presenter)
Lausanne, Switzerland
 A soft disposable contact lens embedding MEMS and telemetry monitoring intraocular pressure continuously and non-invasively.
Sentinel Group LLC (First-Time Presenter)
Grand Rapids, MI
 A removable minimally invasive device to treat obesity by inducing satiety in the esophageal / cardiac portion of the stomach placed via endoscopy (www.SentinelGroupLLC.com).
SonoMedix (First-Time Presenter)
Doylestown, PA

Ultrasound based diagnostic biosensor that enables blood analysis at the molecular level for the multi-billion dollar patient self-test market.

Spinal Elements
Carlsbad, CA
 Zyre™ Facet Arthroplasty System; Minimally invasive, tissue sparing, reversible.

Symbios Medical
Indianapolis, IN
 The Symbios GOPump™ Rapid Recovery System provides postoperative pain relief for patients more effectively than narcotics.
TissueGen, Inc. (First-Time Presenter)
Dallas, TX
 TissueGen is developing ARCHER, a biodegradable, polymer-based, drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries.
Urovalve, Inc.
Newark, NJ
 The Surinate® bladder management system incorporates a miniature, patient-controllable valve into a unique intraurethral catheter that is designed to be easily inserted, function for up to 30 days and be removed without surgery.

Victhom Human Bionics Inc.
Quebec, Canada

Victhom's Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that features neurosensing and neurostimulation components, integrated with artificial intelligence
ViOptix, Inc. (First-Time Presenter)
Fremont, CA		 Optical Diffusion Imaging and Spectroscopy (ODIS) technology which enables non-invasive, direct, real-time measurement of local tissue oxygen saturation.
Vista LifeSciences (First-Time Presenter)
Parker, CO
 ANAM4 is a broad set of neuropsychological cognitive tests. A “test battery builder” function permits researchers and institutions to tailor an assessment for specific use.
Vivostat A/S
Alleroed, Denmark		 Vivostat A/S manufactures and sells a surgical sealant and a gel to treat chronic wounds. Both are based on the individual patients own blood. A third product can be used as a drug delivery media for topical use.

Xylos Corporation
Langhorne, PA

Xylos Corporation is a medical device company that develops unique biomaterials based on proprietary biocellulose technology for the treatment, repair and replacement of human tissue.

Companies with Tabletop Exhibits and Reserved Luncheon Tables on 10/23/08
(on Waiting List for Presentation Slots)

Technologies
POEMS Ltd. (First-Time Presenter)
Tel-Aviv, Israel
  (technology description available soon at http://www.windhover.com/in3east08)

... among several others to be announced soon

 
 

Top reasons to attend In3 East:

  • Catch up on the state of medical technology investment and partnering
  • Network with peers who face similar challenges in regulatory, reimbursement and clinical issues for medical devices
  • Benchmark your dealmaking against the best and the brightest
  • Winners and losers: Find out which companies and technologies are worth the investment
  • Get key trend analysis on medical technology deal structures
  • Maximize your strategic alliance opportunities by meeting business development leaders who’ll share practical advice and strategies on how to structure successful deals
  • Walk away with practical, real-life lessons from some of the most experienced dealmakers in the industry in the medical technology marketplace
  • Attended by senior-level decision-makers from the investment community and major medical technology, biopharmaceutical, biotech, venture capital and other companies
  • More than 50 participating companies
  • 10-minute presentations immediately followed by private, one-on-one meetings with company representatives
  • A range of technologies for such high-growth segments of the medtech industry as interventional cardiology, spinal and orthopedic surgery, drug delivery technology, and stroke management

Maximize your strategic alliance opportunities by hearing C-level, venture capital and business development executives who share lessons learned, practical advice and strategies on medical technology dealmaking.

In3 East has the most senior execs in attendance:

  • Presidents
  • CEOs
  • Chairmen
  • Venture Partners
  • Managing Directors
  • Vice Presidents/Directors of Business Development, Marketing, New Technology, Acquisitions, R & D & Sales
  • Senior Investment Analysts/Managers/Directors

If you're on this list, you must attend this meeting.

  • Established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength
  • Venture capitalists and investment bankers
  • Medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships
back to top

Program Agenda

Wednesday, October 22, 2008
8:00-5:30 p.m. Medical Device Investor Day (Separate Registration Required)

Wednesday, October 22, 2008
5:00-7:00 p.m. Registration & Welcome Reception Essex Ballroom Foyer
6:00-7:00 p.m. Pre-Conference Panel Discussion Essex Ballroom Foyer

Top Strategies: Global Update U.S., India, China - Getting Finance in a Bad Economic Environment

Hosted by:
Chris Velis - Medical Capital Advisors

Thursday, October 23, 2008
7:00-8:00 a.m. Registration & Continental Breakfast Essex Ballroom Foyer
8:00 a.m. Welcome/Opening Essex Ballroom Center
8:00-9:00 a.m.

 Keynote Panel Discussion

Stories behind How Financing Deals got Done
• Why we invested in certain technologies/clinical spaces

• What kind of due diligence got done

• How valuations were determined

• What was the rationale behind the deal from an in investment point of view

Panelists:
David Cassak, FDC-Windhover (moderator)
David Milne, Managing Partner, SV Life Science Advisers LP
Kevin Connors, General Partner, Spray Venture Partners
Amir Nashat, General Partner, Polaris Ventures

Company Presentations
9:05am Moderator - Battelle
9:10 eCardio Diagnostics
9:20 Delcath Systems, Inc.
9:30 Urovalve, Inc.
9:40 FAST
9:50 NeoMend, Inc.
10:00 AugmentRX Medical, Inc.
10:15 Moderator - Medmarc
10:20 Xylos Corporation
10:30 CoreSpine Technologies
10:40 Discovery Technology International, LLP
10:50 Minnow Medical
11:00 Victhom Human Bionics Inc.
11:10 EyeMarker Systems, Inc.
11:25 Moderator - The Medtech Group
11:30 Healionics Corporation
11:40 Envisionier Medical Technologies
11:50 Nerites

12:00 Curative Biosciences, Inc.
12:10 Endosense SA
12:20 nContact Surgical, Inc.
12:30-1:30 p.m. Lunch Essex Ballroom South
1:35 Moderator - Averion
1:40 Polymedix, Inc.
1:50 Vivostat A/S
2:00 Cardiola, Ltd.
2:10 ViOptix Inc.
2:20 Ceragenix Pharmaceuticals
2:30 Genesis Medical Interventional, Inc.
2:45 Moderator - Edwards Angell Palmer & Dodge
2:50 DermTech International
3:00 CardioMag Imaging, Inc.
3:10 mNemoscience GmbH
3:20 PEAK Surgical, Inc.
3:30 LRS Ortho
3:40 Advanced BioSensors, Inc.
3:55 Moderator - PushMed
4:00 EndoSphere Inc.
4:10 Spinal Elements
4:20 Symbios Medical
4:35 Moderator - TATRC
4:40 Infoscitex Corporation
4:50 Science Applications International Corporation
5:00 Vista LifeSciences
5:10 Inovio Biomedical Corporation
5:20 Moderator - Invest In Germany

5:25 Intellwave, LLC
5:35 Scil Technology, GmbH
5:45 Rosetta Genomics
5:55 InspireMD
6:05-6:35 p.m. Sponsor Supported Networking Session 
6:35-8:00 p.m Presenting Company Product Exhibits/Networking Reception - Essex Ballroom South

Friday, October 24, 2008
7:15-8:00 a.m. Registration & Continental Breakfast

8:00-9:00 a.m.

Panel Discussion

FDA Update: Tips for Smooth and Successful Interactions with CDRH

• Get the latest news from Washington on IDEs, PMA review, the 510(k) process, device reclassifications and user fees

• Learn how to use the new Interactive Review process for pre-market submissions

• Understand CDRH’s changing expectations for 510(k) clearance

Panelists:
Mary Houghton, FDC-Windhover (moderator)
Christy Foreman, Acting Deputy Director for Science and Review Policy, FDA Office of Device Evaluation
Laurie A. Clarke, Partner, King & Spalding
David L. West, PhD, MPH, Vice President, Medical Device Development, Quintiles Consulting
Company Presentations
9:05 am Moderator - Medical Capital Advisors
9:10 SonoMedix
9:20 Sensimed AG
9:30 TissueGen, Inc.
9:40 Lerner Medical Devices
9:50 Osprey Medical Inc.
10:05 Moderator - FDC-Windhover
10:10 Cerapedics, Inc.
10:20 MTM Laboratories
10:30 LineaGen, Inc.
10:40 HydroCision, Inc.
10:50 Sentinel Group, LLC
11:05 Moderator - FDC-Windhover
11:10 Diopsys
11:20 MicroTransponder Inc.
11:30 AxoGen, Inc.
11:40 LifeBond Ltd.
11:55 Moderator - FDC-Windhover
12:00 Respirion, Inc.
12:10 Core Essence Orthopaedics LLC
12:20 InSet Inc.
12:30 HemoSonics
12:40 ACell, Inc.

12:50 CVAC Systems, Inc.
1:00 Box Lunch & Conference Concludes

Note: Program subject to change; check back for regular updates.

 

*Cancellation Policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is September 20, 2008. After that, you may send another delegate from your company.
 


Sponsored by:

 

 

 

Financial Contributor

Major Supporting Publication